Hematology & Oncology Headlines

Keytruda® Approved for Small Cell Lung Cancer

Keytruda® Approved for Small Cell Lung Cancer

The Food and Drug Administration (FDA) has granted approval for Keytruda® (pembrolizumab) to treat metastatic small cell lung cancer (SCLC).

Journal Reading List

2019 ASCO Annual Meeting

Conversations with Experts

click me